Illness	Number of cases
Hyperplasia of prostate (N40)	122
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0)	49
Malignant neoplasm of prostate (C61)	47
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	40
Calculus of kidney and ureter - Calculus of kidney (N20.0)	27
Cystitis (N30.2)	21
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	19
Malignant neoplasm of kidney except renal pelvis (C64)	16
Calculus of kidney and ureter - Calculus of ureter (N20.1)	13
Calculus of lower urinary tract - Calculus in bladder (N21.0)	13

Top 10 treatments

Treatment	Number
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	133
Exchange or removal of a tube (catheter) in the kidney for draining urine through the abdominal wall (8-138.0)	108
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	96
Taking a tissue sample (biopsy) of the male reproductive organs through the rectum (1-464.00)	78
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	78
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	66
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4)	63
Other procedure on the kidney, ureter, bladder or urethra (8-139.00)	59
Insertion, exchange or removal of a ureteral stent (8-137.00)	54
X-rays of the kidney and urinary tract with contrast medium (3-13d.6)	48

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
53	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
43	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
43	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)

Training

No.	Training in other healing professions	Comment
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB03	Physical therapist / physiotherapist (m/f)	Es werden Praktikumsplätze für Auszubildende angeboten.
HB19	Nursing professionals
HB10	Midwife (m/f)
HB07	Surgical technical assistant (m/f)